S. 3558 · 118th Congress

Prohibiting Foreign Access to American Genetic Information Act of 2024

Introduced on Dec 20, 2023 by Gary C. Peters (D-MI). 10 cosponsors, 9 of them from another party. Latest action (Sep 23, 2024): Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.

Stage
Reported by committee
Introduced
Dec 20, 2023
Cosponsors
10
9 from the other party
Policy area
Government Operations and Politics
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to prohibit contracting with certain biotechnology providers, and for other purposes.

Subjects

  • Congressional oversight
  • Government information and archives
  • Health technology, devices, supplies
  • Public contracts and procurement

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Gary C. PetersD-MISponsor

Democrats · 1

Republicans · 9

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Dec 20, 2023Introduced in Senate
  2. Dec 20, 2023 · SenateRead twice and referred to the Committee on Homeland Security and Governmental Affairs.
  3. Mar 6, 2024 · SenateCommittee on Homeland Security and Governmental Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. Sep 23, 2024Committee on Homeland Security and Governmental Affairs. Reported by Senator Peters with an amendment in the nature of a substitute. With written report No. 118-229.
  5. Sep 23, 2024 · SenateCommittee on Homeland Security and Governmental Affairs. Reported by Senator Peters with an amendment in the nature of a substitute. With written report No. 118-229.
  6. Sep 23, 2024 · SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 521.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA12 reports
    $23.4M reported (all issues)
  2. FUJIFILM Holdings America Corporation7 reports
    $485K reported (all issues)
  3. WUXI BIOLOGICS USA LLC6 reports
    $295K reported (all issues)
  4. ILLUMINA, INC.5 reports
    Federal contractor: ILLUMINA, INC.$21.9M in contracts, FY2026AI match · 100%
  5. AKEBIA THERAPEUTICS INC.4 reports
    $1.2M reported (all issues)
  6. AMGEN INC.4 reports
    $11.6M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  7. Association of American Universities4 reports
    $244.5K reported (all issues)
  8. BATTELLE MEMORIAL INSTITUTE4 reports
    $970K reported (all issues)Federal contractor: BATTELLE MEMORIAL INSTITUTE$313.9M in contracts, FY2026AI match · 100%
  9. BIOGEN INC.4 reports
    $4.1M reported (all issues)
  10. BIOTECHNOLOGY INNOVATION ORGANIZATION4 reports
    $6.7M reported (all issues)
  11. GSK (fka GLAXOSMITHKLINE INC.)3 reports
    $3.9M reported (all issues)
  12. HARVARD UNIVERSITY--PRESIDENT AND FELLOWS OF HARVARD COLLEGE3 reports
    $490K reported (all issues)
  13. IGM BIOSCIENCES, INC.3 reports
    $240K reported (all issues)
  14. TAKEDA PHARMACEUTICALS AMERICA, INC.3 reports
    $2.5M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  15. BGI Shenzhen Co., Ltd.2 reports
    $370K reported (all issues)
  16. With Honor Action, Inc.2 reports
    $80K reported (all issues)
  17. Amgen USA, Inc.1 report
    $60K reported (all issues)Federal contractor: AMGEN USA INC$126M in contracts, FY2026AI match · 100%
  18. BROWN UNIVERSITY1 report
    $70K reported (all issues)Federal contractor: BROWN UNIVERSITY$1M in contracts, FY2026AI match · 100%
  19. Chamber of Commerce of the U.S.A.1 report
    $23.4M reported (all issues)
  20. Danaher Corporation1 report
    $180K reported (all issues)
  21. EMD SERONO, INC.1 report
    $780K reported (all issues)
  22. Jazz Pharmaceuticals, Inc. and its subsidiaries, including Greenwich Biosciences1 report
    $50K reported (all issues)
  23. Laboratory Corporation of America Holdings1 report
    $810K reported (all issues)Federal contractor: LABORATORY CORPORATION OF AMERICA$7M in contracts, FY2026AI match · 100%
  24. SEQIRUS1 report
    $220K reported (all issues)Federal contractor: SEQIRUS INC$121.6M in contracts, FY2026AI match · 99%
  25. Secretary of State, State of Delaware1 report
    $60K reported (all issues)
  26. WuXi AppTec Sales LLC1 report
    $70K reported (all issues)

Reports filed in 2023, 2024, 2025.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.